Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives
about
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerabilityApproved Antiviral Drugs over the Past 50 Years2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcri[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitroAction of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptaseDifferential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsHuman immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analo1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activityAntiviral therapy for human immunodeficiency virus infectionsIn search of a selective antiviral chemotherapy.
P2860
Q24628212-4363B4D8-A1B9-4373-8289-C9D64D53C62AQ27755387-44257271-3215-4A81-9983-01CBA4652FF9Q28316183-2B3CC2E4-B37A-4B88-A338-117F4D8FB82AQ28318473-4A174C8E-70DF-4516-8C78-534EB252A097Q28367573-552BE298-AB43-4CA3-9AA6-D55811DF819EQ28367677-4FDB2EB1-5389-4CDB-8A5B-B940F2D02915Q28367707-6967680B-452E-4329-ADF9-544187E5128BQ28368045-877C3DC3-61CC-4BCF-8BCD-483ECD9A514BQ28379406-859F8FC8-59EB-4A81-A483-EACFE8945649Q35366050-DCF0E414-9059-42CC-816E-E05637CF4E80Q35375912-DEEAC160-FFEC-4B9F-9851-EF047ED143B3
P2860
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Highly potent and selective in ...... uted acyclouridine derivatives
@ast
Highly potent and selective in ...... uted acyclouridine derivatives
@en
Highly potent and selective in ...... uted acyclouridine derivatives
@nl
type
label
Highly potent and selective in ...... uted acyclouridine derivatives
@ast
Highly potent and selective in ...... uted acyclouridine derivatives
@en
Highly potent and selective in ...... uted acyclouridine derivatives
@nl
prefLabel
Highly potent and selective in ...... uted acyclouridine derivatives
@ast
Highly potent and selective in ...... uted acyclouridine derivatives
@en
Highly potent and selective in ...... uted acyclouridine derivatives
@nl
P2093
P1476
Highly potent and selective in ...... uted acyclouridine derivatives
@en
P2093
H Takashima
R T Walker
P304
P407
P577
1991-06-01T00:00:00Z